Chronic constipation is rarely taken seriously. Doctors dismiss it, patients normalise it — and yet research now shows it can precede a Parkinson’s disease diagnosis by 20 years or more. In this episode, microbiome researcher Martha Carlin joins me to explore the link between Gut Health and Parkinson’s Disease, drawing on over two decades of research — and a deeply personal journey that began when her husband John was diagnosed at just 44 years old.
⚠️ Quick note: Martha co-authored a paper on the glycocalyx and Parkinson’s disease that was accepted for publication in Advances in Colloid and Interface Science just days before we recorded. Some of the most cutting-edge science in this episode comes directly from that work.
GUEST BIO
Martha Carlin is a microbiome researcher and founder of The BioCollective, one of the first independent IRB-approved human microbiome research initiatives in the world. Her work began after her husband was diagnosed with Parkinson’s disease at 44, which led her to spend more than a decade studying microbial ecology, metabolic networks, and the biological systems behind chronic disease.
She led the development of True Matrix, the first standardised human microbiome reference sample used to support microbiome research globally, backed by a $1.2M NIH grant. Martha also founded BiotiQuest, where she develops targeted probiotic formulations built around microbial guilds designed to restore specific biological functions. She is a research fellow at the Australian National University and frequently speaks on microbiome science, metabolic health, and systems-based approaches to chronic disease.
🌐 Martha’s website
EPISODE OVERVIEW
The connection between gut health and Parkinson’s disease is no longer fringe science. Since a landmark 2014 paper showed that gut bacteria could distinguish between the two phenotypes of Parkinson’s disease, over 2,000 papers have been published exploring the gut-brain axis in neurological disease. Martha Carlin has been at the forefront of this research — and in this conversation, she brings together the science, the clinical patterns, and the lived experience of 24 years alongside her husband’s diagnosis.
The gut health and Parkinson’s Disease connection is not just about what happens after diagnosis. The evidence points to a prodromal window of 20 years or more, during which chronic constipation, gut dysbiosis, and microbial imbalance are already present and measurable. This is where early intervention matters most.
WHAT YOU’LL LEARN ABOUT GUT HEALTH AND PARKINSON’S DISEASE
- The gut health and Parkinson’s Disease connection and why it matters for everyone, not just those with a diagnosis
- The two phenotypes of Parkinson’s disease and how gut bacteria can distinguish between them
- Why chronic constipation is a prodromal sign — not a minor inconvenience
- The role of hydrogen sulphide, LPS endotoxins, leaky gut, and microbial imbalance in Parkinson’s pathology
- The mycobacteria connection that almost nobody in mainstream medicine is discussing
- Why Martha’s team could identify Parkinson’s patients simply by looking at stool samples
- How glyphosate decimates the beneficial bacteria most critical to neurological health
- The glycocalyx — what it is, why it is central to Parkinson’s pathology, and whether it can be restored
- The overlooked cardiovascular risks in Parkinson’s disease, Martha’s Sugar Shift probiotic formula, and the specific strains designed to support the gut-brain axis
IN THIS EPISODE, YOU’LL DISCOVER:
✅ Why chronic constipation can precede a Parkinson’s diagnosis by 20+ years — and why it is never normal
✅ The two phenotypes of Parkinson’s disease and how gut bacteria can distinguish between them
✅ The role of hydrogen sulphide, LPS endotoxins, and leaky gut in Parkinson’s pathology
✅ The mycobacteria connection to Parkinson’s that almost nobody is talking about
✅ How glyphosate is decimating the good bacteria we need most — and what you can do about it
✅ The glycocalyx — what it is, why it matters, and how to restore it
✅ The overlooked cardiovascular risks in Parkinson’s disease
✅ Martha’s Sugar Shift probiotic formula and the strains behind it
✅ Where to start if you or someone you love has just received a Parkinson’s diagnosis
THE HIDDEN GUT HEALTH AND PARKINSON’S DISEASE CONNECTION
The gut-first model of Parkinson’s disease proposes that for a significant subset of patients, alpha-synuclein misfolding begins in the enteric nervous system and travels up the vagus nerve to the brain — potentially decades before motor symptoms appear. Martha’s research adds important layers to this picture, including the roles of hydrogen sulphide-producing bacteria, urease-producing pathogens such as H. pylori, LPS endotoxins, and the often-overlooked contribution of mycobacteria.
Perhaps most strikingly, Martha’s team at The BioCollective found that stool samples from Parkinson’s patients were so compacted and hardened — she describes it as the consistency of concrete — that they required a caulking gun to process. This points to a dual mechanism: impaired gut motility from potassium dysregulation, and calcium-driven hardening of stool from microbial battle in the gut.
If chronic constipation is part of your picture, this episode is essential listening.
LISTEN HERE
SHOW NOTES
🌐 Martha Carlin’s website: — biotiquest.com
📖 Martha’s book: My Search for the Perfect Poop — available on Amazon
📄 Upcoming paper: Gut, Brain and the Glycocalyx: A Portrait of Parkinson’s Disease — Advances in Colloid and Interface Science (accepted for publication 2026)
THE LINK BETWEEN CHRONIC CONSTIPATION AND PARKINSON’S DISEASE
One of the most important takeaways from this episode is the significance of chronic constipation as a prodromal sign of Parkinson’s disease. Research consistently shows that constipation can precede a Parkinson’s diagnosis by 20 years or more — yet it is still routinely dismissed in clinical settings as normal or simply a lifestyle issue.
From a clinical perspective, chronic constipation creates the ideal conditions for endotoxin accumulation. When waste lingers in a dysbiotic gut environment, LPS-producing gram-negative bacteria have prolonged contact with the gut lining, driving intestinal permeability, systemic inflammation, and — according to Martha’s research — contributing to the cascade of events that may seed alpha-synuclein misfolding years before a neurologist would diagnose Parkinson’s disease.
If you are seeing patients with chronic constipation, this is not a minor complaint to manage symptomatically. It is a window — and potentially a significant intervention opportunity.
🌿 Chronic constipation is one of the earliest warning signs we have for serious neurological and systemic disease — and it is one of my core clinical specialties. If you have been struggling with constipation, bloating, dysbiosis, or digestive symptoms that nobody has been able to explain, I would love to help you find the root cause.
🫖 Shop BetterMe Tea (Digestive Support)
LISTEN & SUBSCRIBE
Connect with Lynda Griparic: Instagram
This content is for educational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health routine.